Arthur A. Levin - 31 Dec 2025 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Reporting relationship: Director
Issuer ticker: STOK
Reported as of: 31 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Jan 2026, 16:16:22 UTC
Prior SEC filing: 22 Dec 2025
Next SEC filing: 23 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Allan, Attorney-in-Fact

Key filing fact

Arthur A. Levin filed Form 4 for Stoke Therapeutics, Inc. (STOK) on 05 Jan 2026.

Key facts

This page summarizes Arthur A. Levin's Form 4 filing for Stoke Therapeutics, Inc. (STOK).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Jan 2026, 16:16.

Change

Previous filing in this sequence was filed on 22 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001181556 Primary reporting owner

LEVIN ARTHUR A

Relationship: Director
Address: C/O STOKE THERAPEUTICS, INC., 45 WIGGINS AVENUE, BEDFORD
Signature: /s/ Jonathan Allan, Attorney-in-Fact
Signature date: 05 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STOK transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +1,211
Change %: +33%
Price: $0.000000
Shares after: 4,842
Date: 31 Dec 2025
Ownership: Direct

STOK holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 17,979
Date: 31 Dec 2025
Ownership: Arthur A. Levin, Ph.D., Trustee, Butler-Levin Revocable Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STOK transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -1,211
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 31 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,211
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each Restricted Stock Unit represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.

Footnote F2

The award vested or vests as to 1/4 of the total award quarterly on the last day of March, June, September, and December, subject to the reporting person's continued service to the issuer through each vesting date.